A PATIENT WITH HYPERGASTRINEMIA WHO PRESENTED WITH MULTIPLE ESOPHAGO-GASTRODUODENAL ULCER AND WAS OPERATED OF FOR COLONIC CANCER AND ITS HEPATIC METASTASIS AFTER TOTAL GASTRECTOMY
暂无分享,去创建一个
T. Tajiri | M. Onda | A. Tokunaga | N. Matsukura | S. Kato | K. Yamashita | N. Tanaka
[1] B. Hirschowitz,et al. Long‐term treatment with lansoprazole for patients with Zollinger–Ellison syndrome , 1996, Alimentary pharmacology & therapeutics.
[2] L. Villani,et al. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. , 1993, Bailliere's clinical gastroenterology.
[3] L. F. Kolakowski,et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Jensen,et al. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. , 1989, Gastroenterology.
[5] F. Eckhauser,et al. Microgastrinomas of the Duodenum: A Cause of Failed Operations for the Zollinger‐Ellison Syndrome , 1989, Annals of surgery.
[6] R. Jensen,et al. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. , 1985, Gastroenterology.
[7] J. Decosse,et al. Surgical management of the Zollinger-Ellison syndrome. , 1974, The Surgical clinics of North America.
[8] M. Ito,et al. Cholecystokinin-B/gastrin receptor signaling pathway involves tyrosine phosphorylations of p125FAK and p42MAP. , 1994, Oncogene.